Copyright © 1984, American Society for Microbiology
Rapid
Screening
Assay
for Toxic Shock Syndrome Toxin Production
by Staphylococcus
aureus
LANA S. WECKBACH,l* MICHAEL R. THOMPSON,2 JOSEPH L. STANECK,1 AND PETER F. BONVENTRE3 Departments of Pathology and Laborato,y Medicine,1 InternalMedicine, Division ofDigestiveDiseases,2 and
Microbiology
andMolecular Genetics,3
University
of
Cincinnati,
Cincinnati,
Ohio 45267-0714Received 9 January 1984/Accepted 16 March 1984
Arapid immunoblotassay (TST-blot)wasdeveloped and usedtoscreenStaphylococcusaureusisolates for
toxic shock syndrome toxin (TST)production.Growth froman18-hstab inoculum of S.aureusonbrain heart
infusionagar wastransferred directlytoanitrocellulose sheet.Nonspecificprotein binding siteswereblocked with bovineserumalbumin, and the nitrocellulose sheetwasincubated withaffinity-purifiedantibodytoTST, followed by incubation with horseradishperoxidase-conjugated protein A. Toxinwasvisualized by detection of
the peroxidase-conjugated protein A-anti TST-TST complex with 4-chloro-1-napthol. The sensitivities and specificities of the TST-blotandOuchterlony microslide immunodiffusionassaywerecompared byscreening
141S. aureusisolates for TSTproduction.Inbothassays,53of 141 isolates produced detectable levels of TST, whereas 88 isolates producednotoxin.A 100%concordancewasfoundbetweenthetwoassays.TheTST-blot
yielded thesameresultsin less than 24 hasthoseyielded by the 3-day immunodiffusionassay.Thus, this rapid
method fordetection of TSTin multiple samplesappearstobe well suited fordiagnostic and epidemiological studies. Furthermore,itwould appeartobe ideal forusein TST geneticsresearch.
Toxic shock syndrome (TSS), a clinical entity first
de-scribed by Todd et al. (10) in 1978, is a manifestation of
Staphylococcusaureusinfection.Thusfar, theonly reliable marker for identifying S. aureus associated with TSS has
been the production ofa toxin designated staphylococcal enterotoxin F (1) or
pyrogenic
exotoxin C (9). Recent publications (2, 3)haveindicatedthattheseareprobablythe same toxin, and, therefore, the designation toxic shocksyndrome toxin(TST) will be used in this paper.
Three methods for identifying TST are Ouchterlony immunodiffusion (1), isoelectric focusing (9), and Western
blot (2). All three methods require
specialized
instrumenta-tion,and 3 daysormore are required forcompletion ofthe assay. Arapid immunoblotassay(TST-blot) todetect
TST-producing S. aureus has been developed. The TST-blot is
sensitive andspecificandyields interpretable results in less than 24 h.
MATERIALSAND METHODS
Source of isolates. The S.aureusisolates used in this
study
were classified (i) genital non-TSS, (ii) acute TSS, (iii) recoveredTSS, (iv) clinicalnongenital, and (v) food
entero-toxigenic.
Thegenital
non-TSS strainswere collected fromthe labia, fornix, or endocervix of
nonsymptomatic
womenin a S. aureus prevalence survey described
previously
(5).The acute TSS isolates were genital, surgical, or from a
wound and were obtained from hospitalized patients
diag-nosedasconfirmedorpresumptiveTSS. Thesewere
provid-ed by the University of Cincinnati TSS Study Group; W.
Altemeier, University of Cincinnati; and H. Pickrum,
Procter and Gamble Co., Cincinnati, Ohio. The recovered TSS isolatesweregenitaloranteriornarescultures obtained from women cultured 3 months to 2 years after recovery from TSS andwerecollected inconjunctionwith the preva-lence study (5). The clinical nongenital isolates were from
staphylococcal infections andwere
provided
bythe Clinical*Correspondingauthor.
Microbiology Laboratory, University of Cincinnati Medical
Center. The food enterotoxigenic isolates originally were
implicated in food poisoning outbreaks and were proven
enterotoxin producers; they were provided by R. Bennett, Food and Drug Administration, Washington, D.C. All S. aureusisolateswerecodedand frozen in brain heart infusion
(BHI) broth with 20% glycerol before testing for TST
production by microslide immunodiffusion and bythe
TST-blot.
Affinity-purified antiserum for TST. Purified TST and
rabbit antiserum forTST werekindly provided by D. Arch-er, Food and Drug Administration, Cincinnati, Ohio.
Puri-fied TST was coupled to CNBr-activated Sepharose 4B
(Pharmacia FineChemicals) by using theinstructions of the
manufacturer for coupling. The column was prepared by
coupling5 mgofpurifiedTSTto1 gof swollen gel. To obtain
affinity-purified antibody to TST, 7 ml of high-titer rabbit
anti-TST was diluted to a volume of 50 ml in 20 mM
phosphate-bufferedsaline(pH 7.2) and then pumped through thecolumn overnight at 4°C. After the binding ofanti-TST
antibodyto thecolumn, thespecific anti-TSTantibody was eluted with 5 M KI in 50 mM Tris (pH 7.4) at room temperature. The eluted affinity-purified antibody was dia-lyzedextensively against phosphate-bufferedsaline and then
divided and frozen(-80°C).
Immunodiffusion assay. TST was produced for the immunodiffusion assay by the membrane-over-agar method (7),usingBHI agar (DifcoLaboratories). Briefly, S. aureus isolateswereinoculated into4mlof BHI broth and incubat-ed without shaking at 37°C in 7 to 10% CO2 overnight. An inoculum of0.1 ml of each broth culture wasused on agar
platesoverlaid withdialysismembrane (Spectropor12-14K; Fisher Scientific Co.). Inoculatedplates were
incubated
for 18 h at37°C in 7to 10% C02;then 2.5mlof 0.01 Msodiumphosphatebufferwasappliedtotheplates.Aftersuspending
the bacterial mass, organisms were removed by centrifuga-tion,and the supernatantwastestedfor the presence of toxin
by microslide immunodiffusion as previouslydescribed (5).
TSTwasusedat aconcentration of1 ,ug/ml, andantiserum for TST was used at 1:4 dilution. Twenty microliters was
18
on February 8, 2020 by guest
http://jcm.asm.org/
RAPID ASSAY FOR TOXIC SHOCK SYNDROME TOXIN 19
added per well. Standards of TSTandanti-TSTwere provid-ed by M. Bergdoll, University ofWisconsin, Madison.
TST-blot. The following reagents were prepared for the TST-blot:a stocksolutionof 20 mMTris-150mMNaCl(pH
7.4) at 25°C (Tris-saline) and 5% (wt/vol) bovine serum albumin (BSA)-Tris-saline were prepared as described by
Towbin et al. (11). Horseradish peroxidase conjugated to protein A (Protein A POD conjugated; Boehringer
Mann-heim Biochemicals) (protein A-POD) was
used
at a 1:1,000dilution in 5%BSA-Tris-saline. A modification of the
chro-magen visualization procedure described by Hawkes et al. (4) wasused. A stocksolution of3 mg of4-chloro-1-napthol
per ml of methanol was stored at 4°C in the dark and was
diluted with 5 volumes of 50 mM Tris (pH 7.4) and H202
added to 0.015% concentrationjust before use. Protein A-POD was stored at -20°C inportions and diluted just before
use. All other reagents were stored at 4°C. The affinity-purified antiserumforTSTwasdiluted 1:20 in 5% BSA-Tris-salineand stored at
-200C
or4°C,dependingonthefrequen-cy ofuse. Theantiserumwas stabletofreezing and thawing
and was reused several times.
The TST-blot was performed by stab inoculating an ac-tivelygrowing culture from agar orbrothonto BHI agar (Fig. 1). Toscreenorganismsfortoxin production, amaximumof 36 isolates wasinoculated perplate. Plates were incubated
for 18 h at 37°C in 7 to 10% CO2. All additional TST-blot procedures were at room temperature. A cut sheet of nitrocellulose separating paper (blue waxed paper) was placeddirectlyonthe agarsurface andthenquickly lifted to remove mostof the culture growth fromtheagar. Asheet of nitrocellulose (Millipore Corp.) was placed directly on the
agarfor10min, removedwithforceps, and thenplacedagar side upinanemptypetri dish. The sheetwas marked before
removal from the agar to aid in alignment with the culture
plate afterdevelopment.
The nitrocellulose was rinsed three times with 15 ml of 0.05% BSA-Tris-saline with gentle shaking to remove any
adhering growth. Then the nitrocellulose was incubated in
5% BSA-Tris-saline for 30 min without shaking to block nonspecific protein binding sites. The blocking solution was
discarded, affinity-purified antiserum for TST (diluted 1:20 in 5% BSA-Tris-saline) was added, and the sheet was
incubated for 2 h without shaking. The
nitrocellulose
sheet was rinsed in 200 to400
mlofTris-saline
withgentleshaking for 15minto remove unbound antibody and thenincubated
with 15 ml of protein A-POD (1:1,000) for 1 h without shaking. The rinsingprocedure was repeated to remove the residual unbound proteinA.
Finally,
the nitrocellulosesheet was placed in a clean petri dish with freshsubstrate. Areas in which TSTimmunocomplexwas bound to thenitrocellulosewerevisualizedby ablue-purplecolordeveloping within 5to
15 min. After color development, the substrate
was
thor-oughlyrinsed fromthenitrocellulose withwater, andthetest was readimmediately. Any visible colordevelopment (blue-purple) was scored as a positiveTSTproducer. KnownTST-positive
(tox+)
and TST-negative (tox-) isolates werein-cludedwith each assay as controls.
RESULTS
The sensitivity and specificity of theTST-blot were influ-enced by the type ofmedium, concentration ofBSA,
condi-tions ofincubation, and dilution of anti-TST. To determine
anoptimum culture medium for
the
TST-blot, four commer-cially available agarmedia (tryptic soy plus 5% sheep blood[BAP],
Columbia [CNA], tryptic soy [TSA], and BHI) wereeachinoculated with 36 S. aureusisolates,and toxin
produc-InoculateBHI ager incubate 370C, 18 hr
Overlaywithnitrocellulose (NC)
10'
roomtemperature
(RT,
250C)
Wash .05%BSA-Tris-Saline, 5'with
shaking
IncubateNC with5% BSA-Tris saline
30',
RT,stationury
IncubateNC with antiTST
2hr,RT,
stationary
Wash Tris saline
15'
RTIncubateNC with protein A-POD I hr RT
Wash Tris saline 15' RT
Transfer NCtofreshpetridish,incubate in substrate
5-15'
RTRinse tapwater/blot dry- store indark FIG. 1. Flowdiagram of TST-blot procedure.
tion was determined (Fig. 2). Only the S. aureius isolates which were strong TST producers on TSA and BHI were detected onCNA and BAP. TSA gave greatercolor intensity
but
occasionally yielded
false-positives.
BHIyielded
themost reliable and unambiguousresults.
Concentrations of 1 and 5% BSA
blocking
buffers werecompared for
efficiency
inblocking nonspecific
protein bindingsites. The5% BSAyielded
moreconsistentresultsinthe assay. The optimum conditions of incubation were at roomtemperature(25°C)andwithout
shaking.
Incubationat 4 and 42°C in anti-TST and protein A-POD decreased sensitivity, and incubationat37°Cdecreasedspecificity.
The shaking ofthese reagents during incubation increased thenonspecific binding, thus
decreasing
thespecificity
of theassay. Affinity-purified anti-TST also was requiredto elimi-nate the nonspecific cross-reactivity observed with unpuri-fied antitoxin. Adequate color development was observed with antibody dilutions of 1:5 and 1:20 within the 2-h incubation time, but noappreciable color developmentwas found with a 1:50dilution of anti-TST within the sametime
period. TST transferred to the nitrocellulose was easily observed as ablue-purple color on a white background.
Enterotoxigenic food isolateswere usedto testthe
speci-VOL. 20, 1984
on February 8, 2020 by guest
http://jcm.asm.org/
20 WECKBACH ET AL. #."#e ;: ,,,:f' ,4r:: .s :-X>., ,. .g : |,' .,'S: :s: , es: ''.:. ;V:: *x:.'., A
ttsci<
s ; * ,pt vr., ?r .re .;r. 'S :@ 8,$S, :@ :*
.4 : : oW':r, J \<; 4' .SR., ,,, B: :.:. ... .rr s-.. .,., ,,r a^L
.E, , _
'R wr.
i: ,"',*:.ew.
.,, :. ={ ,
*..L'_:
w.. '' SF 0.FIG. 2. Comparison of TST-blot for36 S. aureus isolate
inoculated on four types ofagar culture medium. Nitrocel
from TST-bloton(A) CNA,(B)BAP,(C)BHI, (D)TSA.Dar
areasindicate thepresenceof bound TST immune complex.
ficity of theassay. These 24isolates wereknowntoprc oneormoreof enterotoxinA-E. No cross-reactionwas
withanyofthese isolates in the TST-blot. Asafurthe
for specificity, nitrocellulose was inoculated with pu staphylococcal enterotoxin A, staphylococcal entero
B, and TST. When the TST-blotwas performed, only
gave a positive reaction. No cross-reaction was seen
staphylococcal enterotoxins A orB.
The sensitivities of TST-blotandOuchterlony immur fusionwerecompared since immunodiffusion isan acc
methodfordetecting TST-producing S.aureus(1, 2). A
of 141 S. aureus isolates categorized as genital non-acuteTSS,recoveredTSS, clinical nongenital non-TSS foodenterotoxigenicweretestedby toxin productionin assays (Table 1). A 100% concordance was found bet
theTST-blot and immunodiffusion. WhenaS.aureusis wastox+ inoneassay,itwasalsopositive in the othera
Therefore, under these conditions the TST-blot and (
terlony immunodiffusion wereconsidered equivalent ir sitivity (6 ng) and specificity.
The results of a TST-blot of 36 S. aureus isolate
shown in Fig. 3. The areas ofimmunoprecipitation v
ized as blue-purple spots on nitrocellulose indicates
producing S. aureus. In this assay, 10 of 36 isolates TSTpositive. A reproducible phenomenon observed i TST-blot was that when some S. aureus isolates pros
TST which diffused into themediumsurroundingthec
with otherisolates, TSTwasdetected onlydirectly be
the colony. The feasibility ofdetecting tox+ isolates mixed with (tox-) S. aureus isolates was determine
surface
streaking
BHI agar with anappropriate
diluti tox+ and tox- S. aureus in BHI broth to yield isc colonies. When the areas of immunoprecipitation onitrocellulosewerecomparedtothediscrete coloniesc
BHIagar, only colonieswith pigmentation characteristic of the
tox+
isolate was positive by the TST-blot (Fig. 4).Therefore, tox+ colonies could be distinguished from tox
coloniesby the TST-blot.
IDISCUSSION
Several methods have been developed to identify TST-producing strains of S. aureus. These include Ouchterlony
immunodiffusion (1), isoelectric focusing(9),andan
electro-phoretic transfer procedure (Western blot) (2). All three methodsare relatively time consuming, require specialized
instrumentation or radiolabeled reagents or both, and
re-quireatleast 3 days for interpretable results. The TST-blot utilizes commercially available medium and reagents and does not require any specialized equipment. At least 36
isolates can be tested on a single plate compared with 1
isolateperplate by the membrane-over-agar method. In the
clinical laboratory, an isolated S. aureus colony from a
suspected TSS patient could be used to directly inoculate BHI agar, and TST production could be determined within
24h.Since inaclinical setting onlyoneortwoisolates would be tested ata time, the procedurecan be adapted to small strips of nitrocellulose and can be performed in test tubes with smaller volumes ofreagents (unpublished data). The
s stab sensitivity and specificity of the TST-blot are equivalent to
[lulose
those ofthe immunodiffusion assay.^kened Factors which were controlled inoptimizing theTST-blot procedure were media, incubation conditions, and
concen-tration of anti-TST. When f3AP, CNA, TSA, and BHI agar
werecompared, onlyisolateswhichshowedstrongreactions
on TSAand BHI were also detectedon BAP and CNA by
the TST-blot. TSA (Fig. 20)) gave a more intense color
)duce reaction than did BHI (Fig. 2C), but it also occasionally seen yielded false-positives. BHI gave the most reproducible
rtest result and, therefore, was the medium used in subsequent rified assays. This difference in toxin detection between media )toxin may be a function of a specific nutrient requirement by
TST selected isolatesfor TSTproductionormaybe the resultofa
with component in the media interfering with the assay. Other investigators (8) have shown thatvaryinggrowth conditions nodif- can influence the amount of TST produced by selected S. epted aureusisolates. Another characteristic of TSTproduction by
i total the S.aureustested inthe TST-blotwasthat insomeisolates
-TSS, a halo of toxin surrounded the colonial growth and others
5,and only had toxin under the colony (Fig. 3). This phenomenoh
iboth may reflect hypertoxin or hypotoxin production orperhaps ween
solate issay
:)uch- TABLE 1. Comparisonof TST-blot and immunodiffusionfor
ncn detection ofTST
i sen-s are isual- TST-were in the Juced olony neath when -d by ion of Mlated in the )nthe TSTassays' Source of isolates
Immunodiffusion TST-blot
Genitalnon-TSS' 5/43 5/43
TSS,acutec 42/42 42/42
TSS,recoveredd 3/8 3/8
Clinicalinfectionse, non-TSS 1/24 1/24
Foodenterotoxigenicf 2/24 2/24
aDataarepresentedasnumberofpositives/numberofisolatestested. bGenital carriage isolates were obtained during a prevalence survey conductedbytheTSSStudyGroupof theUniversityofCincinnati(5).
'S. aureus wasisolatedfromclinicallyconfirmed TSS.
d S. aureus isolates werefrom women several months to 2years after clinical TSS.
eClinical isolateswerefrom diverse fociofinfectionfrompatientsatthe University Hospital.
fEnterotoxigenicS. aureus wereincriminated in foodoutbreaks. J. CLIN.MICROBIOL.
on February 8, 2020 by guest
http://jcm.asm.org/
RAPID ASSAY FOR TOXIC SHOCK SYNDROME TOXIN 21
&
-
1~
3
J.
I
lI)
1,/0
9
I
'1S*iiI~'(lDt' 34
,
1
E?A;
14-
1
13
0.
34 .23 RX
it
AD Ii
$o
2f
4
.L7
A
tE
*
3G
3f
43
SX * iFIG. 3. Thirty-six S. aureusisolates screened for TST production by TST-blot.(A)Stab-inoculatedBHIagar;(B)TST-blotnitrocellulose of plate Awith 10tox+ and 26tox- isolates.
may be areflection ofcell-associated versus freely soluble toxin.
Theconditions ofincubation werecontrolledon thebases oftime, temperature, and shaking versus not shaking. The time of incubation for each step is flexible; however, the times given yielded optimum results. When the time of
incubation in BSA was decreased to less than 20 min, an
increase in nonspecific binding was evident. Adecrease in
incubation timeinanti-TSTdecreased sensitivity until weak-erpositives were notevident.Increasingthe
incubation
timein anti-TST did not appreciably increase sensitivity.
De-creasing the time of incubation in protein A-POD also
decreased theintensity of the color reaction. The tempera-tureofincubationwasoptimumat25°C (roomtemperature).
At 4 and 42°C only strong positives were detected by the
TST-blot. Incubation at37°C resulted innonspecific binding
and thus
yielded
severalfalse-positives.
A factor whichappeared
to bemandatory
was notshaking
the solutionsduring
incubation.Shaking
increasednonspecific
binding,
yielding
manyfalse-positives.
Theconcentrationof theanti-TSTwasanother
limiting factor;
asthe concentration ofanti-TSTwas
decreased,
theintensity
of the reaction decreaseduntil no
positives
were evident withinthe 2-h timeperiod.
Using
Western blotanalysis,
we have observed that anumber ofthese S. aiureius isolates
produced
common pep-tides which cross-react with the non-affinity-purifiedanti-TST
(unpublished
data).
Thus,
anaffinity-purified
anti-TSTimmunoglobulin
was needed to achievespecificity
in theTST-blot. The anti-TST was reused several times without
lossof
activity. Therefore,
asmallvolume ofaffinity-purified
antiserum could be used to test hundreds ofisolates. The
specificity
ofanti-TSTwas shown when no cross-reactionsA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
L
FIG. 4. Equalvolumesof BHIbrothsinoculated with tox+and tox-S.aureus andincubatedat37°C for 18 hwerecombined, diluted,and surfacestreaked on BHIagar. (A)Discrete coloniesoftox+and tox- S.aureuson BHIagar;(B)nitrocellulose from TST-blotofplateAwith tox+ colonies visualized.
VOL. 20, 1984
4
I 11
I i-,
on February 8, 2020 by guest
http://jcm.asm.org/
with staphylococcal enterotoxins occurred in the food
en-terotoxigenic isolates. Previous studies (6, 7) have shown
that theenterotoxins areproduced in BHI agar and also can be produced simultaneously with TST (1). Thus although oneormoreenterotoxinswereprobably present in the agar, no false-positives wereobtained with the food isolates.
Several advantages of the immunoblot assay are
envi-sioned. First, theTST-blot may provide a valuable tool in epidemiological studies since large numbers of S. aii-eiis
isolates can be screened rapidly for TST production with minimum handling. Second, in geneticresearch,selectionof
tox+ and tox- isolates or hypertoxin producers is feasible
with thisassay. Finally, clinical laboratories can determine within 24 h whether a suspected TSS patient is colonized with a TST-producing strain of S. aureus.
LITERATURECITED
1. Bergdoll, M.S.,B. A.Crass, R.F. Reiser,R. N. Robbins,and J. P. Davis. 1981.A newstaphylococcal enterotoxin, enterotox-in F, associated with toxic-shock-syndrome. Lancet i:1017-1021.
2. Bonventre,P.F., L.Weckbach, J. Staneck,P. M.Schlievert,and M. Thompson. 1983. Productionofstaphylococcal enterotoxin Fandpyrogenic exotoxin Cby Staphylococcusaureusisolates from toxic shocksyndrome-associatedsources.Infect.Immun. 40:1023-1029.
3. Cohen, M.L., L. M.Graves,P. S. Hayes, R.J. Gibson, J. K.
Rasheed,andJ. C. Feeley.1983.Toxic shocksyndrome: modifi-cation andcomparison of methods fordetecting marker proteins in Staphylococcus aureus. J. Clin. Microbiol. 18:372-375. 4. Hawkes, R., E. Niday, and J. Gordon. 1982. A dot
immunobind-ing assay for monoclonal and otherantibodies. Anal. Biochem. 119:142-147.
5. Linnemann, C. C., J. L. Staneck, S. Hornstein, T. P. Barden, J. L. Rauh,P. F. Bonventre, C. R. Buncher, and A. Beiting. 1982. The epidemiology of genital colonization with Staphvlo-coccus aureus. Ann. Intern. Med. 96:940-944.
6. Meyer, R.F., and M. J. Palmieri. 1980. Single radial immunodif-fusion method for screening staphylococcal isolates for entero-toxin. Appl. Environ. Microbiol. 40:1080-1085.
7. Robbins, R., S. Gould, and M. Bergdoll. 1974. Detecting the enterotoxigenicity of Staphylococcusaureusstrains.Appi. Mi-crobiol.28:946-950.
8. Schlievert, P. M., and D. A. Blomster. 1983. Production of staphylococcalpyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147:236-242.
9. Schlievert,P.M., K. N.Shands,B. B.Dan, G.P.Schmid,and R. D. Nishimura.1981.Identification and characterization ofan exotoxin from Staphylococcus aureus associated with toxic shocksyndrome. J. Infect. Dis. 143:509-515.
10. Todd, J., M. Fishaut, F. Kapral, and T. Welch. 1978. Toxic shock syndrome associated with phage-groupIstaphylococci. Lancetii:1116-1118.
11. Towbin,H.,T.Staehelin,andJ.Gordon. 1979.Electrophoretic transferofproteins from polyacrylamide gelstonitrocellulose sheets: procedure andsomeapplications. Proc. Natl. Acad. Sci. U.S.A. 76:14350-14354.